The number of people infected with the new coronavirus continues to skyrocket, with more than 80,000 cases worldwide as of the end of February. But there's no vaccine or cure in sight, meaning that doctors can do little more ...
Feb 27, 2020
1
321
New research presented at this week's ESCMID Conference on Coronavirus Disease (ECCVID, held online) shows that a shorter time from symptom onset to hospitalisation is associated with more serious disease and death in patients ...
Sep 26, 2020
0
7
A team of researchers at Washington State University has discovered a second DNA-sensing pathway that initiates an antiviral response to foreign genetic material in human cells. In their paper published in the journal Science ...
(HealthDay)—The flu has ramped up in time for Christmas, the head of the U.S. Centers for Disease Control and Prevention said Friday.
Dec 22, 2018
0
37
If you have signs or symptoms of coronavirus disease 2019 (COVID-19), it's important that you contact your health care provider right away for medical advice. But COVID-19, the common cold, seasonal allergies and the flu ...
Jan 11, 2021
0
8
The rapid development of safe and effective COVID-19 vaccines has been a major step forward in helping bring the pandemic under control. But with the rise of variants and an uneven global distribution of vaccines, COVID-19 ...
Aug 10, 2021
3
533
A large, multi-center study refutes earlier suggestions that antiviral drugs for treating hepatitis C may lead to a higher recurrence of liver cancer.
Jan 18, 2019
0
31
Sofosbuvir is one of a number of new direct-acting antiviral drugs revolutionising the care of people living with hepatitis C. Combinations of two or three hepatitis C virus direct-acting antiviral drugs taken for 8-24 weeks ...
Aug 4, 2016
0
3
By discovering a trick the hepatitis C virus uses to evade the immune system, scientists have identified a new antiviral defense system that could be used to treat many virus infections, according to new research published ...
Jun 16, 2020
0
25
Stimulating immune cells with two cancer immunotherapies together can shrink the size of the viral "reservoir" in SIV-infected non-human primates treated with antiviral drugs, researchers have concluded. The reservoir includes ...
Mar 16, 2020
0
74
